ACADIA Pharmaceuticals Inc.

Insiders Updates

Acadia Pharmaceuticals Inc (ACAD) rating initates by Deutsche Bank

Acadia Pharmaceuticals Inc’s filing revealed that its EVP, CHIEF FINANCIAL OFFICER Schneyer Mark C. unloaded Company’s shares for reported $40133.0

Analysts Viewpoint

Acadia Pharmaceuticals Inc (ACAD) rating initates by Deutsche Bank

Acadia Pharmaceuticals Inc’s recently made public that its EVP, CHIEF FINANCIAL OFFICER Schneyer Mark C. unloaded Company’s shares for reported

Analysts Viewpoint

EVP, CHIEF FINANCIAL OFFICER Schneyer Mark C. sale 2,708 shares of Acadia Pharmaceuticals Inc [ACAD]

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Insiders Updates

Analyzing Acadia Pharmaceuticals Inc (ACAD) After Recent Trading Activity

Acadia Pharmaceuticals Inc’s recently made public that its PRINCIPAL ACCOUNTING OFFICER Kihara James unloaded Company’s shares for reported $18670.0 on

Stock Earnings

A company insider recently sold 1,095 shares of Acadia Pharmaceuticals Inc [ACAD]. Should You Sale?

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Insiders Updates

ACAD (Acadia Pharmaceuticals Inc) may reap gains as insiders became active recently

Acadia Pharmaceuticals Inc’s filing revealed that its PRINCIPAL ACCOUNTING OFFICER Kihara James unloaded Company’s shares for reported $18670.0 on Mar

Analysts Viewpoint

Insider Selling: Kihara James, Acadia Pharmaceuticals Inc [ACAD] PRINCIPAL ACCOUNTING OFFICER divested 1,095 shares

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Stock Earnings

Acadia Pharmaceuticals Inc [ACAD] Insider GAROFALO ELIZABETH A. sells 4,919 Shares – Insider Selling Alert

Acadia Pharmaceuticals Inc’s recent filing unveils that its Director GAROFALO ELIZABETH A. unloaded Company’s shares for reported $89673.0 on Mar

Tag: ACADIA Pharmaceuticals Inc.